Detrusor overactivity in spina bifida: How long does it need to be treated?

Neurourology and Urodynamics

Volumn 23, Issue 7, 2004, Pages 685-688

  Ab, E ^a   Dik, Pieter ^a   Klijn, Aart J ^a   Van Gool, Jan D ^a   De Jong, Tom P V M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bladder compliance; Detrusor overactivity; Oxybutynin; Spinabifida

Indexed keywords

OXYBUTYNIN;

ARTICLE; BLADDER CAPACITY; BLADDER COMPLIANCE; BLADDER PRESSURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOMETRY; DETRUSOR DYSSYNERGIA; DOSE TIME EFFECT RELATION; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERMITTENT CATHETERIZATION; LONG TERM CARE; MALE; NEUROGENIC BLADDER; NEUROPATHY; OBSTRUCTIVE UROPATHY; OVERACTIVE BLADDER; SPINA BIFIDA; URETHRA STENOSIS; URODYNAMICS;

CHILD; CHILD, PRESCHOOL; CHOLINERGIC ANTAGONISTS; COMPLIANCE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MANDELIC ACIDS; MUSCLE, SMOOTH; PRESSURE; PROSPECTIVE STUDIES; SPINAL DYSRAPHISM; URINARY BLADDER NECK OBSTRUCTION; URINARY BLADDER, NEUROGENIC; URINARY CATHETERIZATION; URODYNAMICS;

EID: 4744372567     PISSN: 07332467     EISSN: None     Source Type: Journal    
DOI: 10.1002/nau.20044     Document Type: Article

References (11)

1. Dik P, Tsachouridis GD, Klijn AJ, et al. 2003. Detrusorectomy for neuropathic bladder in patients with spinal dysraphism. J Urol 170: 1351-4.
2. Fung TC, Khoury AE, McLorie GA, et al. 1995. Evaluation of pediatric hydronephrosis using individualized pressure flow criteria. J Urol 154:671.
3. German K, Bedwani J, Davies J, et al. 1995. Physiological and morphometric studies into the pathophysiology of detrusor hyperreflexia in neuropathic patients. J Urol 153:1678.
4. van Gool JD, Bloom DA, Butler RJ, et al. 1998. Conservative management in children, development of bladder sphincter control. In: Abrams P, Koury S, Wein A, editors. Incontinence. 1st International Consultation on Incontinence, 1st edn. Chapter V. Plymbridge: United Kingdom, 489-550.
5. van Gool JD, Dik P, de Jong TPVM. 2001. Bladder-spincter dysfunction in myelomeningocele. Eur J Pediatr 160:414.
6. Hjalmas K. 1988. Urodynamics in normal infants and children. Scand J Nephrol Suppl 114:20-27.
7. Holmdahl G, Sillen U, Hellstrom AL, et al. 2003. Does treatment with clean intermittent catheterization in boys with posterior urethral valves affect bladder and renal function? J Urol 170(4 Pt 2):1681-5, discussion 1685.
8. Pannek J, Sommerfeld HJ, Botel U, et al. 2000. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury. Urology 55:358.
9. Park JM, McGuire EJ, Koo HP, et al. 2001. External urethral sphincter dilation for the management of high risk myelomeningocele: 15-year experience. J Urol 165:2383.
10. Riccabona M, Koen M, Schindler M, et al. 2004. Botulinum-A toxin injection into the detrusor: A safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171(2 Pt 1):845-8, discussion 848.
11. Stark GD. 1973. Correlative studies of bladder function in myelomeningocele. Dev Med Child Neurol 15(Suppl 29):55.